Ladiratuzumab vedotin | m-entrepreneurship.com

Product Name :
Ladiratuzumab vedotin

Search keywords :
Ladiratuzumab

drugId :
null

Target Vo:
Zinc transporter ZIP6

Target Vo Short Name :
ZIP6

Moa_Name:
Tubulin polymerisation inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Seagen Inc

Active Company_Name :
Merck Sharp & Dohme LLC

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Caspase-9 Rabbit mAb Autophagy
Clivatuzumab Autophagy
RASA1 Antibody: RASA1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 116 kDa, targeting to RASA1. It can be used for WB,ICC assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts